FDA approves generic version of Jazz Pharma's sleep disorder drug
Read More
Bagikan Berita Ini
Selasa, 17 Januari 2017
News Business
FDA approves generic version of Jazz Pharma's sleep disorder drug
Jazz Pharma's shares were down 4.8 percent at $110 in extended trading.
FDA approves generic version of Jazz Pharma's sleep disorder drug
Read More
Bagikan Berita Ini
FDA approves generic version of Jazz Pharma's sleep disorder drug
Read More
Bagikan Berita Ini
0 Response to "FDA approves generic version of Jazz Pharma's sleep disorder drug"
Posting Komentar